Detalles de la búsqueda
1.
Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201).
Oncologist
; 27(5): 340-e374, 2022 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303078
2.
Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603.
Oncologist
; 27(8): e642-e649, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579511
3.
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
BMC Cancer
; 21(1): 1159, 2021 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715820
4.
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).
Gastric Cancer
; 21(1): 84-95, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28497176
5.
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.
Gastric Cancer
; 21(5): 792-801, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29353332
6.
Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G.
Cancer Sci
; 107(12): 1843-1850, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27712015
7.
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK).
Acta Oncol
; 55(3): 309-17, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26757197
8.
Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
Ann Surg Oncol
; 22(8): 2640-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472647
9.
Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP.
Future Oncol
; 11(4): 617-27, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25686117
10.
Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.
Carcinogenesis
; 35(4): 776-83, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24242331
11.
Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors.
Clin Gastroenterol Hepatol
; 12(2): 292-302.e3, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23962552
12.
Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan.
Cancers (Basel)
; 16(8)2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672586
13.
Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy.
Gan To Kagaku Ryoho
; 38(9): 1461-6, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21945893
14.
A hierarchical hybrid system of integrated longitudinal and lateral control for intelligent vehicles.
ISA Trans
; 106: 200-212, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32674851
15.
An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal cancer to investigate the Impact of Learning Effect).
J Anus Rectum Colon
; 4(2): 79-84, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32346646
16.
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G).
Target Oncol
; 15(5): 623-633, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32960408
17.
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).
Clin Colorectal Cancer
; 19(1): 13-21.e3, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732439
18.
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G).
Eur J Cancer
; 135: 11-21, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32526634
19.
[An autopsied case of thoracic esophageal cancer with polymyositis].
Nihon Shokakibyo Gakkai Zasshi
; 106(6): 787-92, 2009 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-19498309
20.
EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.
Oncotarget
; 8(11): 17810-17818, 2017 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28147317